Trial Profile
Comparison of the effects of fenofibrate and atorvastatin, alone and in combination, in patients with type 2 diabetes mellitus and atherogenic dyslipidaemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2011
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Fenofibrate (Primary)
- Indications Dyslipidaemias; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 08 Feb 2011 New trial record